Valuation: Aoxing Pharmaceutical Company, Inc.

Market Cap 23.62M 20.47M 19.18M 17.49M 32.89M 2.25B 33.39M 226M 88.17M 1.13B 88.7M 86.77M 3.76B P/E 2015
20.1x
P/E 2016 23.2x
Enterprise Value 42.18M 36.55M 34.24M 31.23M 58.72M 4.02B 59.62M 403M 157M 2.01B 158M 155M 6.72B EV / Sales 2015
5.77x
EV / Sales 2016 2.11x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
04/08/17 Aoxing Pharmaceutical Company, Inc. Executive Changes CI
15/05/17 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
13/02/17 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2016 CI
13/11/16 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for First Quarter Ended Sept. 30, 2016 CI
04/10/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Year Ended June 30, 2016 CI
16/05/16 Aoxing Pharmaceutical Company, Inc. Reports Earnings Results for the Third Quarter Ended March 31, 2016 CI
08/02/16 Aoxing Pharmaceutical Company, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2015; Provides Earnings Guidance for the Fiscal Year 2016 CI
01/02/16 Aoxing Pharmaceutical Company, Inc. Announces Executive Changes CI
10/12/15 Aoxing Pharmaceutical Company, Inc. to Supply Zhongtongan to the Insurance System for the City of Shanghai CI
04/12/15 Aoxing Pharmaceutical Company, Inc. Announces Opening of its New Narcotic and Psychotropic Drug Research Center CI
01/12/15 Aoxing Pharmaceutical Company, Inc. Announces Management Changes CI
13/11/15 Aoxing Pharmaceutical Company, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended September 30, 2015 CI
12/10/15 Aoxing Pharmaceutical Company, Inc. Auditor Raises 'Going Concern' Doubt CI
1 month-2.78%
3 months-16.67%
6 months-7.89%
Current year+6.06%
1 week 0
Extreme 0.0035
0
1 month 0
Extreme 0.0035
0
Current year 0
Extreme 0.0016
0.01
1 year 0
Extreme 0.0016
0.01
3 years 0
Extreme 0.0011
0.02
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 0
0.69
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-46.97%+66.67% 1.33M
+1.85%-6.38%-24.91%-49.77% 2.01B
-2.07%-1.34% - - 1.84B
+5.48%-3.84%+4.00%+219.05% 1.41B
-2.96%-5.31%-52.27%+41.07% 1.2B
0.00%+2.08%+279.68%+928.35% 1.12B
-2.33%-3.49%+53.06%+45.51% 1.01B
+3.00%-22.93%+53.70%+251.22% 945M
+3.63%-3.21%+26.80%+76.72% 918M
+9.97%+10.06%+91.26%-4.93% 770M
Average +1.66%-6.08%+42.71%+174.87% 1.12B
Weighted average by Cap. +1.39%-6.87%+43.12%+175.41%

Financials

2015 2016
Net sales 25.48M 22.08M 20.68M 18.87M 35.47M 2.43B 36.02M 243M 95.1M 1.22B 95.67M 93.59M 4.06B 32.33M 28.01M 26.24M 23.94M 45M 3.08B 45.69M 309M 121M 1.54B 121M 119M 5.15B
Net income 5.49M 4.76M 4.46M 4.07M 7.65M 524M 7.77M 52.46M 20.51M 262M 20.63M 20.18M 875M 2.06M 1.79M 1.67M 1.53M 2.87M 197M 2.91M 19.68M 7.69M 98.44M 7.74M 7.57M 328M
Net Debt 24.8M 21.49M 20.14M 18.37M 34.53M 2.37B 35.06M 237M 92.57M 1.18B 93.13M 91.11M 3.95B 18.56M 16.08M 15.07M 13.74M 25.84M 1.77B 26.23M 177M 69.27M 886M 69.68M 68.17M 2.96B
Logo Aoxing Pharmaceutical Company, Inc.
Aoxing Pharmaceutical Company, Inc., through its subsidiary, InfoEd Tech Limited, provides educational technology solutions aimed at overcoming language barriers in the Asia Pacific region. By converting training programs into video formats and utilizing artificial intelligence (AI) for multilingual support, it offers accredited training programs that cater to the needs of professionals across various industries.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. AOXG Stock